What is the address of USIMED?

The registered office of USIMED is located at Rue Neuve(LUT) 57, 6238 Pont-à-Celles.

Is USIMED still active?

Yes. According to the CBE (29 October 2026) USIMED is active, legal situation “Normale toestand”, started on 17 April 2002.

Is USIMED registered on Peppol?

No, USIMED is currently not registered on the Peppol network.

What is the enterprise number of USIMED?

The enterprise number of USIMED is BE0477354420.

When was USIMED founded?

USIMED was founded on 17 April 2002.

Who are the directors of USIMED?

According to the 2024 annual accounts, the directors of USIMED are: Benoît Espeel.

Is USIMED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 April 2002; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did USIMED make in 2024?

USIMED recorded a loss after taxes of € 20,013 in financial year 2024.

What is the revenue of USIMED?

As a small company, USIMED is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 81,196.

USIMED (Private Limited) - Pont-à-Celles - BE0477354420

Dossier USIMED, printed on 29 October 2026 from databakkes.be/en/0477354420/usimed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2023 and 2024.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2024

USIMED from Pont-à-Celles, company number BE0477354420, closed financial year 2024 with a result of € -20,013 after tax. For that financial year USIMED recorded a gross margin of € 81,196 and equity of € 309,849. Compared with financial year 2023, the result moved from € -21,660 to € -20,013. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2025.

What it is worth Healthy

€ 309,849

▼ 6% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -20,013

▲ 8 % less loss than in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 48,268

▲ 86% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 297,449.

People and assets in 2024

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 36,588

▲ 166% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 119,598 Gross margin 2021: € 119,598 First fiscal year in the series	€ 95,550 Gross margin 2022: € 95,550 ▼ 20% vs 2021 (€ 119,598) Unfavourable step	€ 66,634 Gross margin 2023: € 66,634 ▼ 30% vs 2022 (€ 95,550) Unfavourable step	€ 81,196 Gross margin 2024: € 81,196 ▲ 22% vs 2023 (€ 66,634) Favourable step	▲ 22%
Profit after taxes	€ 20,875 Profit after taxes 2021: € 20,875 First fiscal year in the series	€ -2,066 Profit after taxes 2022: € -2,066 ▼ € 22,941 vs 2021 (€ 20,875) Unfavourable step	€ -21,660 Profit after taxes 2023: € -21,660 ▼ € 19,593 vs 2022 (€ -2,066) Unfavourable step	€ -20,013 Profit after taxes 2024: € -20,013 ▲ € 1,647 vs 2023 (€ -21,660) Favourable step	▲ € 1,647
Equity	€ 353,587 Equity 2021: € 353,587 First fiscal year in the series	€ 351,521 Equity 2022: € 351,521 ▼ 1% vs 2021 (€ 353,587) Unfavourable step	€ 329,862 Equity 2023: € 329,862 ▼ 6% vs 2022 (€ 351,521) Unfavourable step	€ 309,849 Equity 2024: € 309,849 ▼ 6% vs 2023 (€ 329,862) Unfavourable step	▼ 6%
Total debts	€ 15,599 Total debts 2021: € 15,599 First fiscal year in the series	€ 4,525 Total debts 2022: € 4,525 ▼ 71% vs 2021 (€ 15,599) Favourable step	€ 170 Total debts 2023: € 170 ▼ 96% vs 2022 (€ 4,525) Favourable step	€ 14,661 Total debts 2024: € 14,661 ▲ € 14,491 vs 2023 (€ 170) Unfavourable step	▲ € 14,491
Cash	€ 45,256 Cash 2021: € 45,256 First fiscal year in the series	€ 41,726 Cash 2022: € 41,726 ▼ 8% vs 2021 (€ 45,256) Unfavourable step	€ 25,914 Cash 2023: € 25,914 ▼ 38% vs 2022 (€ 41,726) Unfavourable step	€ 48,268 Cash 2024: € 48,268 ▲ 86% vs 2023 (€ 25,914) Favourable step	▲ 86%
Retained profit	€ 341,187 Retained profit 2021: € 341,187 First fiscal year in the series	€ 339,121 Retained profit 2022: € 339,121 ▼ 1% vs 2021 (€ 341,187) Unfavourable step	€ 317,462 Retained profit 2023: € 317,462 ▼ 6% vs 2022 (€ 339,121) Unfavourable step	€ 297,449 Retained profit 2024: € 297,449 ▼ 6% vs 2023 (€ 317,462) Unfavourable step	▼ 6%
Dividend	€ 800 Dividend 2021: € 800 First fiscal year in the series	€ 0 Dividend 2022: € 0 ▼ 100% vs 2021 (€ 800) Unchanged	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 369,186 Balance sheet total 2021: € 369,186 First fiscal year in the series	€ 356,046 Balance sheet total 2022: € 356,046 ▼ 4% vs 2021 (€ 369,186) Unchanged	€ 330,032 Balance sheet total 2023: € 330,032 ▼ 7% vs 2022 (€ 356,046) Unchanged	€ 324,510 Balance sheet total 2024: € 324,510 ▼ 2% vs 2023 (€ 330,032) Unchanged	▼ 2%

Key figures of USIMED, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to USIMED?

What happened at USIMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2025 New annual accounts for financial year 2024: loss of € 20,013. filed late Source: NBB ↗
Apr 17, 2002 Start of the company according to the CBE. KBO
Mar 15, 2002 New establishment in Pont-à-Celles. KBO

In short

From € 20,875 profit in 2021 to € 20,013 loss in 2024.

Paid € 12,474 in corporate taxes since 2021.

Best year ever: 2021, with € 20,875 profit.

Paid out € 800 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Benoît Espeel

USIMED

Behind USIMED is Benoît Espeel.

Directors

According to the 2024 annual accounts

Benoît Espeel

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Neuve(LUT) 57

6238 Pont-à-Celles

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0477.354.420
VAT number: BE 0477.354.420
Registered office: Rue Neuve(LUT) 57, 6238 Pont-à-Celles
Names & denominations: USIMED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 April 2002
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗